You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1251 to 1275 of about 6040
Next 25
04/09/2019
Case Report in the Journal of Neurosurgery Highlights Potential of ONC201 in H3 K27M-mutant DIPG
Optune Open Houses
04/03/2019
Phase 2 study of Val-083 with radiation therapy for newly diagnosed
New Glioblastoma Vaccine Shows Promising Results in Phase 1b Clinical Trial
High frequency of H3K27M immunopositivity in adult thalamic glioblastoma.
03/31/2019
New glioblastoma vaccine shows promising results in phase Ib clinical trial
Could £400-per-year drug cocktail be the key to beating one of the most-deadly cancers?
03/28/2019
New Strategies Take On the Worst Cancer—Glioblastoma
03/20/2019
Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma.
03/15/2019
First-Of-Its-Kind Treatment Beats Back Notorious Brain Tumor
03/14/2019
03/13/2019
Newly Diagnosed Glioblastoma: A Review on Clinical Management
03/12/2019
A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma
Northwell neurosurgeons remove “glowing” brain tumor using breakthrough technology in Long Island first
xCures to Implement an Intermediate Size Expanded Access Protocol for ONC201 in H3 K27M-mutant Gliomas
03/10/2019
Triple-drug Therapy With Bevacizumab, Irinotecan, and Temozolomide Plus Tumor Treating Fields for Recurrent Glioblastoma: A Retrospective Study.
03/09/2019
Update on Medicare CAC meeting
National Walk To End Brain Tumors
Optune Open House
03/05/2019
Brain tumor advocacy alert - we need you to watch this video Wednesday Morning 3/6/19 at 9am Eastern Time!
03/02/2019
Parkinson’s and cancer hope from implant drilled into skull to deliver drugs with pinpoint precision
The sneaky way estrogen drives brain metastasis in non-estrogen-dependent breast cancers
02/27/2019
Medicare meeting about Optune! Tune in this Wednesday March 6, 2019
02/23/2019
Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database.
02/22/2019
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial